Back to search
Parenteral Nutrition Associated Cholestasis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Parenteral Nutrition Associated Cholestasis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Parenteral Nutrition Associated Cholestasis trials you may qualify forEvaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of pare…
This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source…
Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.
This is an expanded access protocol for use of intravenous fish oil infusion, Omegaven, in infants and children with parenteral nutrition associated liver disea…
The purpose of this study is to determine whether Omegaven is effective in the treatment of parenteral nutrition associated liver disease (PNALD).